PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jonker JT et al. – In T2DM patients, pioglitazone increases pericardial fat volume. This increase in pericardial fat volume did not negatively affect myocardial function after 24 wk. These observations question the notion of an inverse causal relationship between pericardial fat volume and myocardial function.


   

Related Articles

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09    Relevance Score: 94%

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09    Relevance Score: 93%

Pioglitazone Induced Reversible Pancytopenia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09    Relevance Score: 93%

Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes
Acta Diabetologia, 10/08/09    Relevance Score: 93%

Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09    Relevance Score: 92%

Today in Clinical Pharmacology...keeping you current

Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/19/10

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Fibrinolytic agents for peripheral arterial occlusion
Cochrane Reviews, 03/19/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address